ArticleFrontiers in cell and developmental biology2021

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy.

Shaoxian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.